Fresenius Medical Care Q3 2026 net income drops 42% year over year to EUR 160 million

By Public Technologies
  • Fresenius Medical Care’s third-quarter 2026 net income fell 42% year over year to EUR 160 million.
  • Revenue rose to EUR 4.94 billion, while operating cash flow climbed 8% year over year to EUR 798 million.
  • Care Enablement swung to an operating loss of EUR 32 million, mainly due to one-time costs related to its China strategy refinement.
  • The 5008X CAREsystem rollout replaced approximately 16% of U.S. clinic dialysis machines, remaining on track for the 2026 target of around 20%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. FMC - Fresenius Medical Care AG published the original content used to generate this news brief on November 03, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.
 

Cryptocurrency-related content is intended solely as news and market commentary. Crypto Derivatives are not available to Retail clients registered with Capital Com (UK) Ltd.